Similar articles

• Use of botulinum toxin in the treatment of cervical dystonia.

  Poewe W, Wissel J. Poewe W, et al. Baillieres Clin Neurol. 1993 Apr;2(1):179-85. Baillieres Clin Neurol. 1993. PMID: 8143072 Review.
• [Dystonia as the cause of pharyngolaryngeal motility disorders].

  Zwirner P, Dressler D. Zwirner P, et al. HNO. 1995 Aug;43(8):498-501. HNO. 1995. PMID: 7558908 German.
• Treatment with botulinum toxin in a patient with myasthenia gravis and cervical dystonia.

  Fasano A, Bentivoglio AR, Ialongo T, Soleti F, Evoli A. Fasano A, et al. Neurology. 2005 Jun 28;64(12):2155-6. doi: 10.1212/01.WNL.0000165997.77985.32. Neurology. 2005. PMID: 15985599 No abstract available.
• Botulinum toxin type B: an open-label, dose-escalation, safety and preliminary efficacy study in cervical dystonia patients.

  Cullis PA, O'Brien CF, Truong DD, Koller M, Villegas TP, Wallace JD. Cullis PA, et al. Adv Neurol. 1998;78:227-30. Adv Neurol. 1998. PMID: 9750919 Clinical Trial. No abstract available.
• Botulinum toxin treatment of axial and cervical dystonia.

  Benecke R, Dressler D. Benecke R, et al. Disabil Rehabil. 2007 Dec 15;29(23):1769-77. doi: 10.1080/01421590701568262. Disabil Rehabil. 2007. PMID: 18033602 Review.